Disease | portal hypertension |
Phenotype | C0019196|hepatitis c |
Sentences | 5 |
PubMedID- 23553276 | Treatment for hepatitis c virus-induced portal hypertension in leukemic children. |
PubMedID- 22121492 | A platelet count <160,000 × 10(9)/l is 80% sensitive in detecting portal hypertension from cirrhosis in patients with chronic hepatitis c [5]. |
PubMedID- 26205377 | The incidence of portal hypertension (pht) with post-hepatitis cirrhosis is higher in china than elsewhere worldwide. |
PubMedID- 23954997 | Exclusion criteria were as follows: a) receiving interferon (ifn) or nucleoside analogues antiviral therapy in the last 2 years; b) a history of fever in the past 6 months; c) clinical and/or biochemical signs of chronic active hepatitis (spider angiomas, liver palm, splenomegaly, decreased serum albumin, or portal hypertension); d) co-infection with hepatitis c virus, hepatitis d virus or human immunodeficiency virus; e) coexisting serious medical or psychiatric illness; f) organ or bone marrow transplantation; g) recent treatment with systemic corticosteroids, immunosuppressants, or chemotherapeutic agents; h) a serum alpha-fetoprotein levels over 50 ng/ml. |
PubMedID- 20655032 | Nonalcoholic steatohepatitis can lead to portal hypertension, which can further manifest as upper gastrointestinal bleeding. |
Page: 1